Industry News
Pharmaceutical Industry News
Corium, bouncing back from FDA rejection, snags PDUFA date for weekly Alzheimer’s patch
Corium, bouncing back from FDA rejection, snags PDUFA date for weekly Alzheimer's patch ntaylor Tue, 10/19/2021 - 04:58
Roche lands approval to slash Gazyvaro infusion time in EU, bringing treatment in line with MabThera
Roche lands approval to slash Gazyvaro infusion time in EU, bringing treatment in line with MabThera ntaylor Tue, 10/19/2021 - 04:54
Russian team gets green light to trial nasal COVID-19 vaccine but lacks funding to start study
Russian team gets green light to trial nasal COVID-19 vaccine but lacks funding to start study ntaylor Tue, 10/19/2021 - 04:50
F.D.A. to Allow ‘Mix and Match’ Approach for Covid Booster Shots
The agency may act this week, when it is expected to authorize booster shots for recipients of the Moderna and Johnson & Johnson vaccines.
Boehringer’s interchangeable tag for Humira biosim is a ‘landmark’ win for the field: analyst
Boehringer's interchangeable tag for Humira biosim is a 'landmark' win for the field: analyst esagonowsky Mon, 10/18/2021 - 15:39
Regeneron, Novo Nordisk, Lilly and AbbVie stake claims on September’s list of top TV ad spenders
Regeneron, Novo Nordisk, Lilly and AbbVie stake claims on September's list of top TV ad spenders tstaton Mon, 10/18/2021 - 13:52
FDA delays decision on Moderna’s COVID-19 vaccine in 12-17 age group because of myocarditis concerns: WSJ
FDA delays decision on Moderna's COVID-19 vaccine in 12-17 age group because of myocarditis concerns: WSJ kdunleavy Mon, 10/18/2021 - 11:23
Pandemic launch woes: Esperion cuts 40% of workforce, goes all in on cholesterol drug’s outcomes trial
Pandemic launch woes: Esperion cuts 40% of workforce, goes all in on cholesterol drug's outcomes trial aliu Mon, 10/18/2021 - 10:35
Pfizer, Moderna will rake in a combined $93 billion next year on COVID-19 vaccine sales: report
Pfizer, Moderna will rake in a combined $93 billion next year on COVID-19 vaccine sales: report kdunleavy Mon, 10/18/2021 - 10:23
FDA knocks down United Therapeutics’ dry powder Tyvaso application on manufacturing issue
FDA knocks down United Therapeutics’ dry powder Tyvaso application on manufacturing issue jkeenan Mon, 10/18/2021 - 10:04
Revance’s Botox rival turned away by FDA after inspectors flagged manufacturing ‘deficiencies’
Revance's Botox rival turned away by FDA after inspectors flagged manufacturing 'deficiencies' esagonowsky Mon, 10/18/2021 - 09:15
Will New Covid Treatments Be as Elusive for Poor Countries as Vaccines?
Merck has taken a step to make its antiviral pill available in poor nations, but many obstacles remain for broad access to coronavirus drugs.
Roche ushers early lung cancer into immunotherapy era with Tecentriq FDA approval. Will doctors follow?
Roche ushers early lung cancer into immunotherapy era with Tecentriq FDA approval. Will doctors follow? aliu Sat, 10/16/2021 - 12:55
Elizabeth Holmes Trial: Key Moments From Week 6
Testimony addressed the question of whether Theranos was misleading and deceiving big corporations to get money.
Johnson & Johnson wins FDA panel backing for a second dose of its COVID shot but don’t call it a ‘booster’
Johnson & Johnson wins FDA panel backing for a second dose of its COVID shot but don’t call it a ‘booster’ kdunleavy Fri, 10/15/2021 - 15:25
A Racial Disparity in Schizophrenia Diagnoses in Nursing Homes
Diagnoses for the disorder have soared in the past decade, driven in part by a loophole in regulations. A new study shows the impact has been more severe for Black Americans.
Bayer, CureVac part ways on COVID-19 vaccine: reports
Bayer, CureVac part ways on COVID-19 vaccine: reports jkeenan Fri, 10/15/2021 - 10:43
Despite Merck’s oral COVID-19 drug, antibodies by Regeneron, GSK and others still have billions in sales ahead: analyst
Despite Merck's oral COVID-19 drug, antibodies by Regeneron, GSK and others still have billions in sales ahead: analyst aliu Fri, 10/15/2021 - 10:08
Johnson & Johnson puts talc headache into bankruptcy; plaintiffs will contest the ploy
Johnson & Johnson puts talc headache into bankruptcy; plaintiffs will contest the ploy kdunleavy Fri, 10/15/2021 - 09:02
Fierce Pharma Asia—Takeda’s cell, gene therapy deals; BMS-BeiGene Abraxane brawl
Fierce Pharma Asia—Takeda's cell, gene therapy deals; BMS-BeiGene Abraxane brawl aliu Fri, 10/15/2021 - 05:47